Have a personal or library account? Click to login
A Historical Overview of the Role of Benzodiazepines including Clonazepam in the Treatment of Adult Restless Legs Syndrome and Periodic Limb Movements in Sleep Cover

A Historical Overview of the Role of Benzodiazepines including Clonazepam in the Treatment of Adult Restless Legs Syndrome and Periodic Limb Movements in Sleep

Tremor and Other Hyperkinetic Movements
Volume 14 (2024): Issue 1
By: Arthur S. Walters,  Karen Spruyt,  Djibril M. Ba and  Xiang Gao  
Open Access
|May 2024

References

  1. 1Gao X, Ba DM, Bagai K, Liu G, Ma C, Walters AS. Treating Restless Legs Syndrome was associated with low risk of cardiovascular disease: A cohort study with 3.4 years of follow up. Journal of the American Heart Association. 2021; 10: e018674. PMID 33550813. DOI: 10.1161/JAHA.120.018674
    Back to article
  2. 2Carlos K, Prado GF, Teixeira CDM, Conti C, de Oliveira MM, Prado LBF, et al. Benzodiazepines for restless legs syndrome (Review). Cochrane Database of Systematic Reviews. 2017, issue 3, Art. No. CD006939. pp. 1–16. DOI: 10.1002/14651858.CD006939.pub2
    Back to article
  3. 3Yeh PG, Spruyt K, DelRosso LM, Walters AS. A narrative review of the lesser known medications for treatment of Restless Legs Syndrome and pathogenetic implications for their use. Tremor and Other Hyperkinetic Movements. 2023; 13(1): 7, pp. 1–26. DOI: 10.5334/tohm.739
    Back to article
  4. 4Rulong G, Dye T, Simakajornboon N. Pharmacological management of Restless Legs Syndrome and Periodic Limb Movement Disorder in children. Pediatr Drugs. 2018; 20: 9–17. DOI: 10.1007/s40272-017-0262-0
    Back to article
  5. 5Picchietti D. Restless legs syndrome and periodic limb movement disorder in children. UpToDate Literature review current through Dec 2023. Topic last updated. Jul 5, 2023; 1–38.
    Back to article
  6. 6Walters AS, LeBrocq C, Dhar A, Hening W, Rosen R, Allen RP, et al. International Restless Legs Syndrome Study Group. Validation of the International Restless Legs Syndrome Study Group Rating Scale for Restless Legs Syndrome. Sleep Medicine. 2003; 4: 121–132. DOI: 10.1016/S1389-9457(02)00258-7
    Back to article
  7. 7Shinno H, Oka Y, Otsuki M, Tsuchiya S, Mizuno S, Kawada S, et al. Proposed dose equivalence between clonazepam and pramipexole in patients with restless legs syndrome. Progress in Neuro-psychopharmacology & Biological Psychiatry. 2010; 34: 522–526. DOI: 10.1016/j.pnpbp.2010.02.011
    Back to article
  8. 8Matthews WB. Treatment of the restless legs syndrome with clonazepam. British Medical Journal. 1979 March 17; 1(6165): 751. DOI: 10.1136/bmj.1.6165.751
    Back to article
  9. 9Read DJ, Feest TG. Clonazepam: effective treatment for restless legs syndrome in uraemia. British Medical Journal. 1981; 283: 885–886. DOI: 10.1136/bmj.283.6296.885-a
    Back to article
  10. 10Oshtory MA, Vijayan N. Clonazepam treatment of insomnia due to sleep myoclonus. Ach Neurol. 1980; 37: 119–120. DOI: 10.1001/archneur.1980.00500510077019
    Back to article
  11. 11Montagna P, Sassoli de Bianchi L, Zucconi M, Cirignotta F, Lugaresi E. Clonazepam and vibration in restless legs syndrome. Acta Neurol Scand 1984; 69: 428–430. DOI: 10.1111/j.1600-0404.1984.tb07826.x
    Back to article
  12. 12Rousseau JJ, Debatisse DF. Clinical and polygraphic study of 2 cases of “nocturnal myoclonus” sensitive to clonazepam. Acta Neurol Belg. 1985; 85(S): 318–326.
    Back to article
  13. 13Ohanna N, Peled R, Rubin A-H E, Zomer J, Lavie P. Periodic leg movements in sleep: Effect of clonazepam treatment. Neurology. 1985; 35: 408–411. DOI: 10.1212/WNL.35.3.408
    Back to article
  14. 14Peled R, Lavie P. Double-blind evaluation of clonazepam on periodic leg movements in sleep. Journal of Neurology, Neurosurgery and Psychiatry. 1987; 50: 1679–1681. DOI: 10.1136/jnnp.50.12.1679
    Back to article
  15. 15Mitler MM, Browman CP, Menn SJ, Gujavarty K, Timms RM. Nocturnal myoclonus: Treatment efficacy of clonazepam and temazepam. Sleep. 1986; 9: 385–392. DOI: 10.1093/sleep/9.3.385
    Back to article
  16. 16Boghen D. Successful treatment of restless legs syndrome with clonazepam. Ann Neurol. 1980; 8: 341. DOI: 10.1002/ana.410080322
    Back to article
  17. 17Boghen D, Lamothe L, Elie R, Godbout R, Montplaisr J. The treatment of the restless legs syndrome with clonazepam: A prospective controlled study. Canadian Journal of Neurological Sciences. 1986; 13: 245–247. DOI: 10.1017/S0317167100036350
    Back to article
  18. 18Montplaisir J, Godbout R, Boghen D, DeChamplain J, Young SN, Lapierre G et al. Familial Restless Legs with Periodic Movements in Sleep: Electrophysiologic, biochemical and pharmacologic study. Neurology. 1985; 35: 130–134. DOI: 10.1212/WNL.35.1.130
    Back to article
  19. 19Horiguchi J, Inami Y, Sasaki A, Nishimatsu O, Sukegawa T. Periodic leg movements in sleep with restless legs syndrome: effect of clonazepam treatment. The Japanese Journal of Psychiatry and Neurology 1992; 46: 727–732. DOI: 10.1111/j.1440-1819.1992.tb00548.x
    Back to article
  20. 20Edinger JD, Fins AJ, Sullivan RJ, Marsh GR, Dailey DS, Young M. Comparison of cognitive-behavioral therapy and clonazepam for treating periodic limb movement disorder. Sleep. 1996; 19: 442–444.
    Back to article
  21. 21Saletu M, Anderer P, Saletu-Zyhlarz G, Prause W, Semler B, Zoghlami A, et al. Restless legs syndrome (RLS) and periodic limb movement disorder Acute placebo-controlled sleep laboratory studies with clonazepam. European Neuropsychopharmacology. 2001; 11: 153–61. DOI: 10.1016/S0924-977X(01)00080-3
    Back to article
  22. 22Manconi M, Ferri R, Zucconi M, Bassetti CL, Fulda S, Arico D, et al. Dissociation of periodic leg movements from arousals in restless legs syndrome. Ann Neurol. 2012; 71: 834–844. DOI: 10.1002/ana.23565
    Back to article
  23. 23Roshi, Tandon VR, Mahajan A, Sharma S, Khajuria V. A prospective, randomized, open-label study comparing the efficacy and safety of clonazepam versus nortriptyline on quality of life in 40+ years old women presenting with restless leg syndrome. J Midlife Health. 2018; 9: 135–139. DOI: 10.4103/jmh.JMH_25_18
    Back to article
  24. 24Roshi, Tandon VR, Mahajan A, Sharma S, Khajuria V. Comparative efficacy and safety of clonazepam versus nortriptyline in restless leg syndrome among forty plus women: A prospective, open-label randomized study. J Midlife Health. 2019; 10: 197–203. DOI: 10.4103/jmh.JMH_26_18
    Back to article
  25. 25Bonnet MH, Arand DL. The use of triazolam in older patients with periodic leg movements, fragmented sleep, and daytime sleepiness. Journal of Gerontology. 1990; 45: M139–M144. DOI: 10.1093/geronj/45.4.M139
    Back to article
  26. 26Bonnet MH, Arand DL. Chronic use of triazolam in patients with periodic leg movements, fragmented sleep and daytime sleepiness. Aging. 1991; 3: 313–324. DOI: 10.1007/BF03324027
    Back to article
  27. 27Doghramji K, Browman CP, Gaddy JR, Walsh JK. Triazolam diminishes daytime sleepiness and sleep fragmentation in patients with periodic leg movements in sleep. Journal of Clinical Psychopharmacology. 1991; 11: 284–290. DOI: 10.1097/00004714-199110000-00002
    Back to article
  28. 28Scharf MB, Brown L, Hirschowitz J. Possible efficacy of alprazolam in restless leg syndrome. Hillside J. Clin Psychiatry. 1986; 8: 214–23.
    Back to article
  29. 29Moldofsky H, Tullis C, Quance G, Lue FA. Nitrazepam for periodic movements in sleep (sleep-related myoclonus). The Canadian Journal of Neurological Sciences. 1986; 13: 52–54. DOI: 10.1017/S0317167100035794
    Back to article
  30. 30Sateia M (ed.), Walters AS (section editor.). Sleep Related Movement Disorders. Periodic Limb Movement Disorder. The International Classification of Sleep Disorders, 3rd edition. American Academy of Sleep Medicine 2510 N. Frontage Road, Darien, IL, 2014, pp. 292–299.
    Back to article
  31. 31Berry RB, Quan SF (eds.), Walters AS (section editor.). Movement Rules. Scoring Periodic Limb Movements in Sleep The AASM Manual for the scoring of sleep and associated events: Rules, terminology and technical specifications. Version 2.6, American Academy of Sleep Medicine 2510 N. Frontage Road, Darien, IL, 2020, pp. 51–53.
    Back to article
  32. 32Schachter SC. Antiseizure medications: Mechanism of action, pharmacology, and adverse effects. UpToDate: Last updated Jan 6, 2023. Literature review current through May; 2023
    Back to article
  33. 33Airagnes G, Pelissolo A, Lavallee M, Flament M, Limosin F. Benzodiazepine misuse in the elderly: Risk factors, consequences, and management. Curr Psychiatry Rep 2016; 18(10): 89: 1–9. DOI: 10.1007/s11920-016-0727-9
    Back to article
  34. 34Schenck CH, Mahowald MW. Long-term, nightly benzodiazepine treatment of injurious parasomnias and other disorders of disrupted nocturnal sleep in 170 adults. The American Journal of Medicine. 1996; 100: 333–337. DOI: 10.1016/S0002-9343(97)89493-4
    Back to article
  35. 35Goldschen-Ohm MP. Benzodiazepine modulation of GABA A receptors: A mechanistic perspective. Biomolecules. 2022; 12: 1784 (1–14). DOI: 10.3390/biom12121784
    Back to article
  36. 36Winkelman JW, Schoerning L, Platt S, Jensen JE. Restless legs syndrome and central nervous system gamma-aminobutyric acid: preliminary associations with periodic limb movements in sleep and restless leg symptom severity. Sleep Medicine. 2014; 15: 1225–1230. DOI: 10.1016/j.sleep.2014.05.019
    Back to article
  37. 37Zhang R, Werner A, Hermann W, Brandt MD, Beste C, Stock A-K. Thalamic GABA may modulate cognitive control in restless legs syndrome. Neuroscience Letters. 2019; 712: 134494. DOI: 10.1016/j.neulet.2019.134494
    Back to article
  38. 38Jimenez-Jimenez FJ, Esguevillas G, Alonso-Navarro H, Zurdo M, Turpin-Fenoll L, Millan-Pascual J, et al. Gamma-aminobutyric acid (GABA) receptors genes polymorphisms and risk for restless legs syndrome. The Pharmacogenomics Journal. 2018; 18: 565–577. DOI: 10.1038/s41397-018-0023-7
    Back to article
  39. 39Stokes PRA, Myers JF, Kalk NJ, Watson BJ, Erritzoe D, Wilson SJ, et al. Acute increases in synaptic GABA detectable in the living human brain: a [11C] R015–4513 PET study. Neuroimage. 2014; 99: 158–65. DOI: 10.1016/j.neuroimage.2014.05.035
    Back to article
  40. 40Pulman J, Hutton JL, Marson AG. Tiagabine add-on for drug-resistant partial epilepsy. Xoxhrante Databse Syst Rev. 2014; 2014(2): CD001908. DOI: 10.1002/14651858.CD001908.pub3
    Back to article
DOI: https://doi.org/10.5334/tohm.824 | Journal eISSN: 2160-8288
Journal RSS Feed
Language: English
Submitted on: Oct 10, 2023
Accepted on: Mar 21, 2024
Published on: May 2, 2024
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Restless Legs Syndrome (RLS),
Periodic Limb Movements in Sleep (PLMS),
benzodiazepines,
clonazepam,
nitrazepam,
temazepam,
triazolam,
alprazolam

© 2024 Arthur S. Walters, Karen Spruyt, Djibril M. Ba, Xiang Gao, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 14 (2024): Issue 1Next article